Here is link to study: a1c reduction, weight benefits, lower side effectsonce it goes PO (for needle averse) & cost lowered (maybe?) - I see it utilized even more wondering how plans are building this inside their MLR strategy The metformin-to-GLP-1 shift in first-line prescribing is one of the fastest I have seen across any therapy class
Tous ces facteurs environnementaux augmentent la prsence de radicaux libres dans le corps, favorisent le stress oxydatif et acclrent le vieillissement
FDA-approved with 15-17% body weight reduction demonstrated in Phase 3 STEP trials
It is really for those who have a medical need for the drugs, then it would be covered. The insurance department had to ask the legislature for permission to make the change, according to North Dakota Republican House Speaker Robin Weisz
those at intermediate or high risk may proceed to Enhanced Liver Fibrosis (ELF) testing or FibroScan, with referral to hepatology for those with suspected advanced fibrosis, in line with NICE guidance (NG49)